about
Zika Virus–Associated Cognitive Impairment in Adolescent, 2016Cognitive functioning one month and one year following febrile status epilepticus.Resilience in children diagnosed with a chronic neuromuscular disorderSelective deficits in verbal working memory associated with a known genetic etiology: the neuropsychological profile of duchenne muscular dystrophy.Parental stress in mothers of boys with duchenne muscular dystrophy.Three wishes and psychological functioning in boys with duchenne muscular dystrophy.Mutational spectrum of DMD mutations in dystrophinopathy patients: application of modern diagnostic techniques to a large cohort.Poor facial affect recognition among boys with duchenne muscular dystrophyLongitudinal assessment of skill development in children with first febrile seizure.Cerebral metabolic abnormalities in A3243G mitochondrial DNA mutation carriers.Digit Span Performance in Children with Dystrophinopathy: A Verbal Span or Working Memory Contribution?Epinephrine inhibits feeding nonspecifically in the rat.Factors associated with microcephaly at school age in a very-low-birthweight population.Acute hyperglycemia produces transient improvement in glucose transporter type 1 deficiency.Delayed developmental language milestones in children with Duchenne's muscular dystrophy.Premutation female carriers of fragile X syndrome: a pilot study on brain anatomy and metabolism.Cognitive and adaptive deficits in young children with Duchenne muscular dystrophy (DMD).Influence of breastfeeding on cognitive outcomes at age 6-8 years: follow-up of very low birth weight infants.Brain glucose supply and the syndrome of infantile neuroglycopenia.Combined injection potentiates the satiety effects of pancreatic glucagon, cholecystokinin, and bombesin.Topography of brain glucose hypometabolism and epileptic network in glucose transporter 1 deficiency.Ethics of neuroimaging in pediatric development.Adult fragile X syndrome: neuropsychology, brain anatomy, and metabolism.Cognitive and molecular aspects of fragile X.Long-term clinical course of Glut1 deficiency syndrome
P50
Q29572597-48F7061F-490D-4256-AC69-62AEE1482704Q31139865-45A0CBAE-839F-4571-82FC-2EBC84628036Q35553021-A3CC9130-DDCF-4DBB-8BA9-A48393441122Q35910717-20E1C79F-B236-426E-98FC-5C0CD04FAEA6Q35910722-118AB6EF-ACDB-4CA7-86D4-A750D139E401Q35944743-0F026D28-27B1-4C56-B167-EC86CEDD5F59Q36116293-1CD11556-F313-4BAD-844D-40F85A6D1399Q36157368-AEC943F7-3656-44FF-92DF-E0960DE7FCBBQ36971852-3B4A8313-4454-425F-B2A6-680824F67A1CQ37623186-B0BD6BA1-36A6-406F-A01E-651D41E4C5D3Q39705490-9ABC1651-23EC-4A83-8C3C-986CB6951001Q41460578-0FD6D6FA-D6EC-45CD-BE87-189EE54C17A2Q41921652-D101EE5C-05E5-486D-9ABE-A5F28C93A83BQ41937006-5C1C11DA-9CFD-4030-BDC1-A2A925408F55Q42434322-07783E67-DD79-48B4-95D1-CA67C3DDA5FEQ44097487-CB64EC54-01F0-4AB8-98FD-6CD6ADFE0A66Q44950622-8A9A92AB-F822-4F9A-A963-32FC9CBA6409Q47436538-DE0D6B33-5371-4EDA-A98E-FBAD4BCD9673Q48274769-BA4C81FB-005F-4348-8D2C-0BD59C86D13DQ48278684-73051514-28C1-4008-B79E-62F95BF6FA2BQ48363043-F60C0735-FE78-45E9-95C3-62D3BFC15157Q48426888-2E856ED6-326E-4AD6-91BC-4B8021B1EA3CQ50303452-EDBFE5CE-23BA-4D72-9FF1-D4D535CC9656Q52014520-D4DF9C2B-B350-422F-9210-0DCE70FE546AQ87796724-9A600912-6522-4B78-8632-27E8A1C02E38
P50
description
researcher ORCID ID = 0000-0003-2196-2631
@en
name
Veronica J Hinton
@ast
Veronica J Hinton
@en
Veronica J Hinton
@es
Veronica J Hinton
@nl
type
label
Veronica J Hinton
@ast
Veronica J Hinton
@en
Veronica J Hinton
@es
Veronica J Hinton
@nl
prefLabel
Veronica J Hinton
@ast
Veronica J Hinton
@en
Veronica J Hinton
@es
Veronica J Hinton
@nl
P1153
7003894525
P21
P31
P496
0000-0003-2196-2631